{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:37:18Z","timestamp":1792190238381,"version":"4.4.0"},"reference-count":108,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The National Key Research and Development Program of China","award":["No. 2022YFD2200101-04"],"award-info":[{"award-number":["No. 2022YFD2200101-04"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>A new round of monkeypox virus has emerged in the United Kingdom since July 2022 and rapidly swept the world. Currently, despite numerous research groups are studying this virus and seeking effective treatments, the information on the open reading frame, inhibitors, and potential targets of monkeypox has not been updated in time, and the comprehension of monkeypox target ligand interactions remains a key challenge. Here, we first summarized and improved the open reading frame information of monkeypox, constructed the monkeypox inhibitor library and potential targets library by database research as well as literature search, combined with advanced protein modeling technologies (Sequence-based and AI algorithms-based homology modeling). In addition, we build monkeypox virus Docking Server, a web server to predict the binding mode between targets and substrate. The open reading frame information, monkeypox inhibitor library, and monkeypox potential targets library are used as the initial files for server docking, providing free interactive tools for predicting ligand interactions of monkeypox targets, potential drug screening, and potential targets search. In addition, the update of the three databases can also effectively promote the study of monkeypox drug inhibition mechanism and provide theoretical guidance for the development of drugs for monkeypox.<\/jats:p>","DOI":"10.1371\/journal.pone.0303501","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T18:25:42Z","timestamp":1733509542000},"page":"e0303501","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs: A WEB prediction approach"],"prefix":"10.1371","volume":"19","author":[{"given":"Huaichuan","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanshan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueteng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoxin","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7367-3968","authenticated-orcid":true,"given":"Jianping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"pone.0303501.ref001","first-page":"537","article-title":"MPV caused less worry than COVID-19 among the general population during the first month of the WHO monkeypox alert: Experience from Saudi Arabia","volume":"49","author":"M.H. Temsah","year":"2022","journal-title":"Travel. Med. Infect. Di."},{"issue":"2","key":"pone.0303501.ref002","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human monkeypox","volume":"58","author":"A.M. McCollum","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"19","key":"pone.0303501.ref003","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMra2208860","article-title":"Monkeypox","volume":"387","author":"A. Gessain","year":"2022","journal-title":"New. Engl. J. Med."},{"issue":"9","key":"pone.0303501.ref004","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40265-022-01742-y","article-title":"Prevention and treatment of monkeypox","volume":"82","author":"J.G. Rizk","year":"2022","journal-title":"Drugs."},{"issue":"7","key":"pone.0303501.ref005","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMp2210125","article-title":"Tecovirimat and the treatment of monkeypox\u2014past, present, and future considerations","volume":"387","author":"A. Sherwat","year":"2022","journal-title":"New. Engl. J. Med."},{"issue":"8","key":"pone.0303501.ref006","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"H. Adler","year":"2022","journal-title":"Lancet. Infect. Dis."},{"issue":"2","key":"pone.0303501.ref007","doi-asserted-by":"crossref","first-page":"e0010141","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox\u2014A potential threat? A systematic review","volume":"16","author":"E.M. Bunge","year":"2022","journal-title":"PLoS. Neglect. Trop. D."},{"issue":"4","key":"pone.0303501.ref008","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ana.26473","article-title":"An overview of monkeypox and its neuroinvasive potential","volume":"92","author":"D.M. Pastula","year":"2022","journal-title":"Ann. Neurol."},{"issue":"10355","key":"pone.0303501.ref009","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S0140-6736(22)01528-8","article-title":"Human monkeypox infection in an immunocompromised man: trial with tecovirimat","volume":"400","author":"L.E. Hernandez","year":"2022","journal-title":"Lancet."},{"issue":"2","key":"pone.0303501.ref010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jama.2022.10802","article-title":"Monkeypox in 2022\u2014what clinicians need to know","volume":"328","author":"J. Guarner","year":"2022","journal-title":"JAMA."},{"issue":"9","key":"pone.0303501.ref011","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2471\/BLT.19.242347","article-title":"Modelling human-to-human transmission of monkeypox. B","volume":"98","author":"R. Grant","year":"2020","journal-title":"World Health Organ."},{"issue":"8","key":"pone.0303501.ref012","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox infection in humans across 16 countries-April-June 2022","volume":"387","author":"J.P. Thornhill","year":"2022","journal-title":"New Engl. J. Med."},{"issue":"9","key":"pone.0303501.ref013","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/vaccines10091419","article-title":"Preventing the next pandemic: is live vaccine efficacious against monkeypox, or is there a need for killed virus and mRNA vaccines?","volume":"10","author":"A. Abdelaal","year":"2022","journal-title":"Vaccines"},{"issue":"8","key":"pone.0303501.ref014","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","article-title":"Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus","volume":"28","author":"J. Isidro","year":"2022","journal-title":"Nat. Med."},{"key":"pone.0303501.ref015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40064-016-1713-8","article-title":"Need of cost-effective vaccines in developing countries: What plant biotechnology can offer?","volume":"5","author":"M.T. Waheed","year":"2016","journal-title":"SpringerPlus"},{"issue":"13","key":"pone.0303501.ref016","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1021\/acs.jpclett.3c00087","article-title":"Identification and investigation of a cryptic binding pocket of the P37 envelope protein of monkeypox virus by molecular dynamics simulations","volume":"14","author":"G.P.S. Sen","year":"2023","journal-title":"The Journal of Physical Chemistry Letters"},{"issue":"9","key":"pone.0303501.ref017","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2217\/fvl.13.76","article-title":"Orthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012","volume":"8","author":"D.F. Smee","year":"2013","journal-title":"Future Virol."},{"key":"pone.0303501.ref018","doi-asserted-by":"crossref","first-page":"105182","DOI":"10.1016\/j.antiviral.2021.105182","article-title":"Benefit-risk assessment for brincidofovir for the treatment of smallpox: US Food and Drug Administration\u2019s Evaluation","volume":"195","author":"K Chan-Tack","year":"2021","journal-title":"Antiviral research"},{"issue":"1","key":"pone.0303501.ref019","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/cid\/ciac622","article-title":"Antivirals With Activity Against Mpox: A Clinically Oriented Review","volume":"76","author":"E.A. Siegrist","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"13","key":"pone.0303501.ref020","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/jama.2022.15336","article-title":"Compassionate use of tecovirimat for the treatment of monkeypox infection","volume":"328","author":"A.N. Desai","year":"2022","journal-title":"JAMA"},{"issue":"12","key":"pone.0303501.ref021","doi-asserted-by":"crossref","first-page":"e01226","DOI":"10.1128\/aac.01226-22","article-title":"New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human monkeypox virus","volume":"66","author":"C.E. DeLaurentis","year":"2022","journal-title":"Antimicrob. Agents. Ch."},{"issue":"9","key":"pone.0303501.ref022","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/v14091870","article-title":"A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging monkeypox Outbreak","volume":"14","author":"M. Almehmadi","year":"2022","journal-title":"Viruses"},{"issue":"13","key":"pone.0303501.ref023","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s40265-018-0967-6","article-title":"Tecovirimat: first global approval","volume":"78","author":"S.M. Hoy","year":"2018","journal-title":"Drugs"},{"issue":"9","key":"pone.0303501.ref024","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/08927022.2019.1579327","article-title":"3D-QSAR and Molecular recognition of Klebsiella pneumoniae NDM-1 inhibitors","volume":"45","author":"H.C. Duan","year":"2019","journal-title":"Mol, Simulat"},{"issue":"5","key":"pone.0303501.ref025","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1002\/jmv.26678","article-title":"Coronapp: a web application to annotate and monitor SARS\u2010CoV\u20102 mutations","volume":"93","author":"D. Mercatelli","year":"2021","journal-title":"J. Med. Virol."},{"issue":"23","key":"pone.0303501.ref026","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1093\/bioinformatics\/bty407","article-title":"Nextstrain: real-time tracking of pathogen evolution","volume":"34","author":"J. Hadfield","year":"2018","journal-title":"Bioinformatics"},{"issue":"20","key":"pone.0303501.ref027","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1093\/bioinformatics\/btaa645","article-title":"COVID-19 Docking Server: A meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19","volume":"36","author":"R. Kong","year":"2020","journal-title":"Bioinformatics"},{"key":"pone.0303501.ref028","unstructured":"Studio,D. (2008) Discovery studio. Accelrys, [2.1]."},{"issue":"7873","key":"pone.0303501.ref029","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"J. Jumper","year":"2021","journal-title":"Nature"},{"issue":"D1","key":"pone.0303501.ref030","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"M. Varadi","year":"2022","journal-title":"Nucleic. Cids. Res."},{"issue":"12","key":"pone.0303501.ref031","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/prot.26257","article-title":"Applying and improving AlphaFold at CASP14","volume":"89","author":"J. Jumper","year":"2021","journal-title":"Proteins"},{"issue":"10","key":"pone.0303501.ref032","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1021\/acs.jcim.1c01114","article-title":"AlphaFold 2: why it works and its implications for understanding the relationships of protein sequence, structure, and function","volume":"61","author":"J. Skolnick","year":"2021","journal-title":"J. Chem. Inf. Model"},{"key":"pone.0303501.ref033","first-page":"589","article-title":"Docker for multi-containers web application","author":"V. Sharma","year":"2020","journal-title":"ICIMIA"},{"key":"pone.0303501.ref034","doi-asserted-by":"crossref","unstructured":"Rokicki,T. and Maurice.C. (2021) Laperdrix P. Sok: In search of lost time: A review of javascript timers in browsers\/\/2021 IEEE European Symposium on Security and Privacy (EuroS&P). IEEE., 472\u2013486.","DOI":"10.1109\/EuroSP51992.2021.00039"},{"issue":"15","key":"pone.0303501.ref035","first-page":"99","article-title":"Construction of training platform for teachers professional ability of normal students based on ThinkPHP","volume":"4","author":"J. Li","year":"2021","journal-title":"Frontiers in Educational Research"},{"key":"pone.0303501.ref036","first-page":"36256","article-title":"Controllers in SDN: A review report","volume":"6","author":"M. Paliwal","year":"2018","journal-title":"IEEE."},{"issue":"4","key":"pone.0303501.ref037","doi-asserted-by":"crossref","DOI":"10.1029\/2007GC001893","article-title":"GEOMAGIA50: an archeointensity database with PHP and MySQL","volume":"9","author":"K. Korhonen","year":"2008","journal-title":"Geochem. Geophy. Geosy."},{"key":"pone.0303501.ref038","doi-asserted-by":"crossref","first-page":"108752","DOI":"10.1016\/j.comnet.2021.108752","article-title":"Optimized task scheduling for cost-latency trade-off in mobile fog computing using fuzzy analytical hierarchy process","volume":"206","author":"E. Hosseini","year":"2022","journal-title":"Comput. Netw."},{"key":"pone.0303501.ref039","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.ijbiomac.2022.11.145","article-title":"Recognition and release of uridine and hCNT3: From multivariate interactions to molecular design","volume":"223","author":"H.C. Duan","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"pone.0303501.ref040","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1021\/acs.jcim.8b00312","article-title":"Evaluation of AutoDock and AutoDock Vina on the CASF-2013 benchmark","volume":"58","author":"T. Gaillard","year":"2018","journal-title":"J. Chem. Informat. Model."},{"issue":"22","key":"pone.0303501.ref041","doi-asserted-by":"crossref","first-page":"12147","DOI":"10.1128\/JVI.78.22.12147-12156.2004","article-title":"New class of orthopoxvirus antiviral drugs that block viral maturation","volume":"78","author":"C.M. Byrd","year":"2004","journal-title":"J. Virol."},{"issue":"1","key":"pone.0303501.ref042","doi-asserted-by":"crossref","first-page":"e1009183","DOI":"10.1371\/journal.ppat.1009183","article-title":"Orthopoxvirus K3 orthologs show virus-and host-specific inhibition of the antiviral protein kinase PKR","volume":"17","author":"C. Park","year":"2021","journal-title":"PLoS pathog"},{"issue":"4","key":"pone.0303501.ref043","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.jinf.2022.07.001","article-title":"Targeting F13 from monkeypox and variola virus by tecovirimat: Molecular simulation analysis","volume":"85","author":"D. Li","year":"2022","journal-title":"J. Infection."},{"issue":"2","key":"pone.0303501.ref044","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2012.02.012","article-title":"Orthopoxvirus targets for the development of new antiviral agents","volume":"94","author":"M.N. Prichard","year":"2012","journal-title":"Antivir. Res."},{"issue":"44","key":"pone.0303501.ref045","doi-asserted-by":"crossref","first-page":"16900","DOI":"10.1073\/pnas.0804525105","article-title":"Crystal structure of poxvirus thymidylate kinase: an unexpected dimerization has implications for antiviral therapy","volume":"105","author":"C. Caillat","year":"2008","journal-title":"P. Natl. Acad. Sci."},{"issue":"16","key":"pone.0303501.ref046","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.3390\/molecules27165277","article-title":"In silico repurposed drugs against monkeypox virus","volume":"27","author":"H.L. Yuen In","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"pone.0303501.ref047","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nsmb.1529","article-title":"Rapid evolution of protein kinase PKR alters sensitivity to viral inhibitors","volume":"16","author":"S. Rothenburg","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"2","key":"pone.0303501.ref048","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1097-2765(02)00590-7","article-title":"X-ray crystal structure and functional analysis of vaccinia virus K3L reveals molecular determinants for PKR subversion and substrate recognition","volume":"10","author":"A.C. Dar","year":"2002","journal-title":"Mol. Cell"},{"issue":"4","key":"pone.0303501.ref049","doi-asserted-by":"crossref","first-page":"e3000217","DOI":"10.1371\/journal.pbio.3000217","article-title":"How host genetics dictates successful viral zoonosis","volume":"17","author":"C.J. Warren","year":"2019","journal-title":"PLoS biology."},{"key":"pone.0303501.ref050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0065-3527(06)66002-8","article-title":"In a nutshell: structure and assembly of the vaccinia virion","volume":"66","author":"R.C. Condit","year":"2006","journal-title":"Adv. Virus Res."},{"issue":"12","key":"pone.0303501.ref051","doi-asserted-by":"crossref","first-page":"e1002446","DOI":"10.1371\/journal.ppat.1002446","article-title":"The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components","volume":"7","author":"J.P. Laliberte","year":"2011","journal-title":"PLoS Pathog."},{"issue":"17","key":"pone.0303501.ref052","doi-asserted-by":"crossref","first-page":"8422","DOI":"10.1128\/JVI.00599-10","article-title":"Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells","volume":"84","author":"S.J. Chang","year":"2010","journal-title":"J. Virol."},{"issue":"5","key":"pone.0303501.ref053","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.80.5.2127-2140.2006","article-title":"Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles","volume":"80","author":"C.S. Chung","year":"2006","journal-title":"J. Virol."},{"issue":"3","key":"pone.0303501.ref054","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.celrep.2013.06.028","article-title":"Vaccinia virus entry is followed by core activation and proteasome-mediated release of the immunomodulatory effector VH1 from lateral bodies","volume":"4","author":"F. I. Schmidt","year":"2013","journal-title":"Cell Rep."},{"key":"pone.0303501.ref055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.virusres.2017.01.027","article-title":"The vaccinia virus DNA polymerase and its processivity factor","volume":"234","author":"M.W. Czarnecki","year":"2017","journal-title":"Virus. Res."},{"issue":"12","key":"pone.0303501.ref056","doi-asserted-by":"crossref","first-page":"e79953","DOI":"10.1371\/journal.pone.0079953","article-title":"Genome-wide comparison of cowpox viruses reveals a new clade related to Variola virus","volume":"8","author":"P.W. Dabrowski","year":"2013","journal-title":"PLoS ONE"},{"issue":"28","key":"pone.0303501.ref057","doi-asserted-by":"crossref","first-page":"24702","DOI":"10.1074\/jbc.M111.222216","article-title":"Evaluation of the role of the vaccinia virus uracil DNA glycosylase and A20 proteins as intrinsic components of the DNA polymerase holoenzyme","volume":"286","author":"K.A. Boyle","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"23","key":"pone.0303501.ref058","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.1128\/JVI.01435-10","article-title":"Vaccinia virus D4 mutants defective in processive DNA synthesis retain binding to A20 and DNA","volume":"84","author":"A.M. Druck Shudofsky","year":"2010","journal-title":"J. Virol."},{"issue":"6","key":"pone.0303501.ref059","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1074\/jbc.M511239200","article-title":"Vaccinia virus uracil DNA glycosylase interacts with the A20 protein to form a heterodimeric processivity factor for the viral DNA polymerase","volume":"281","author":"E.S. Stanitsa","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"53","key":"pone.0303501.ref060","doi-asserted-by":"crossref","first-page":"27087","DOI":"10.1074\/jbc.M116.761908","article-title":"A Conserved Tripeptide Sequence at the C Terminus of the Poxvirus DNA Processivity Factor D4 Is Essential for Protein Integrity and Function","volume":"291","author":"M. Nuth","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"1","key":"pone.0303501.ref061","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"R.J. Youle","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"pone.0303501.ref062","doi-asserted-by":"crossref","first-page":"e909","DOI":"10.1038\/cddis.2013.436","article-title":"Structural biology of the Bcl-2 family and its mimicry by viral proteins","volume":"4","author":"M. Kvansakul","year":"2013","journal-title":"Cell Death Dis"},{"issue":"15","key":"pone.0303501.ref063","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.1128\/JVI.01092-14","article-title":"Structural insight into BH3 domain binding of vaccinia virus antiapoptotic F1L","volume":"88","author":"S. Campbell","year":"2014","journal-title":"J. Virol."},{"issue":"3","key":"pone.0303501.ref064","doi-asserted-by":"crossref","first-page":"e1680","DOI":"10.1038\/cddis.2015.52","article-title":"Variola virus F1L is a Bcl-2-like protein that unlike its vaccinia virus counterpart inhibits apoptosis independent of Bim","volume":"6","author":"B. Marshall","year":"2015","journal-title":"Cell Death Dis."},{"issue":"3","key":"pone.0303501.ref065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bj.2021.07.004","article-title":"The binding and specificity of chemokine binding proteins, through the lens of experiment and computation","volume":"45","author":"L.E. Stark","year":"2022","journal-title":"Biomed. J"},{"issue":"9","key":"pone.0303501.ref066","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1099\/0022-1317-82-9-2095","article-title":"The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence","volume":"82","author":"A. Ng","year":"2001","journal-title":"J. Gen. Virol."},{"issue":"1","key":"pone.0303501.ref067","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1099\/vir.0.81417-0","article-title":"Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy","volume":"87","author":"R.H. Clark","year":"2006","journal-title":"J. Gen. Virol."},{"issue":"1","key":"pone.0303501.ref068","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1371\/journal.ppat.0040005","article-title":"Structure and function of A41, a vaccinia virus chemokine binding protein","volume":"4","author":"M.W. Bahar","year":"2008","journal-title":"PLoS Pathog"},{"issue":"3","key":"pone.0303501.ref069","doi-asserted-by":"crossref","first-page":"716","DOI":"10.47108\/jidhealth.Vol5.Iss3.231","article-title":"Monkeypox in the COVID-19 era","volume":"5","author":"A.M. Lazar","year":"2022","journal-title":"J. Id. Health"},{"issue":"2","key":"pone.0303501.ref070","doi-asserted-by":"crossref","first-page":"447S","DOI":"10.1093\/ajcn\/83.2.447S","article-title":"Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process","volume":"83","author":"C.A. Dinarello","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"pone.0303501.ref071","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.virol.2006.08.019","article-title":"Variola virus IL-18 binding protein interacts with three human IL-18 residues that are part of a binding site for human IL-18 receptor alpha subunit","volume":"358","author":"X. Meng","year":"2007","journal-title":"Virology"},{"issue":"52","key":"pone.0303501.ref072","doi-asserted-by":"crossref","first-page":"20711","DOI":"10.1073\/pnas.0809086106","article-title":"Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein","volume":"105","author":"B. Krumm","year":"2008","journal-title":"PNAS"},{"issue":"3","key":"pone.0303501.ref073","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.4049\/jimmunol.171.3.1164","article-title":"IL-18 binding protein protects against contact hypersensitivity","volume":"171","author":"T. Plitz","year":"2003","journal-title":"J. Immunol."},{"issue":"33","key":"pone.0303501.ref074","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1073\/pnas.1810398115","article-title":"Structural basis for the inhibition of poxvirus assembly by the antibiotic rifampicin","volume":"115","author":"D. Garriga","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5191","key":"pone.0303501.ref075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/222341a0","article-title":"Rifampicin inhibits the growth of some mammalian viruses","volume":"222","author":"J.H. Subak-Sharpe","year":"1969","journal-title":"Nature"},{"key":"pone.0303501.ref076","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.virol.2006.09.031","article-title":"Amino acid substitutions at multiple sites within the vaccinia virus D13 scaffold protein confer resistance to rifampicin","volume":"359","author":"J.C. Charity","year":"2007","journal-title":"Virology"},{"issue":"3","key":"pone.0303501.ref077","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1128\/AAC.2.3.181","article-title":"Rifamycins: Modulation of specific anti-poxviral activity by small substitutions on the piperazinyliminomethyl side chain","volume":"2","author":"B. Moss","year":"1972","journal-title":"Antimicrob. Agents. Ch"},{"issue":"24","key":"pone.0303501.ref078","doi-asserted-by":"crossref","first-page":"12298","DOI":"10.1128\/JVI.75.24.12298-12307.2001","article-title":"The A20R protein is a stoichiometric component of the processive form of vaccinia virus DNA polymerase","volume":"75","author":"N. Klemperer","year":"2001","journal-title":"J. Virol"},{"issue":"2","key":"pone.0303501.ref079","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.virol.2007.02.016","article-title":"A targeted approach to identification of vaccinia virus postreplicative transcription elongation factors: genetic evidence for a role of the H5R gene in vaccinia transcription","volume":"363","author":"S.G. Cresawn","year":"2007","journal-title":"Virology"},{"issue":"2","key":"pone.0303501.ref080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/viro.2002.1721","article-title":"Mapping interaction sites of the A20R protein component of the vaccinia virus DNA replication complex","volume":"303","author":"K. Ishii","year":"2002","journal-title":"Virology"},{"issue":"17","key":"pone.0303501.ref081","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1128\/JVI.76.17.8973-8976.2002","article-title":"The vaccinia virus I7L gene product is the core protein proteinase","volume":"76","author":"C.M. Byrd","year":"2002","journal-title":"J. Virol."},{"key":"pone.0303501.ref082","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/bs.enz.2021.09.004","article-title":"Viral proteases: Structure, mechanism and inhibition","volume":"50","author":"J. Zephyr","year":"2021","journal-title":"Enzymes"},{"issue":"3","key":"pone.0303501.ref083","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/156802610790725470","article-title":"Recent advances in targeting viral proteases for the discovery of novel antivirals","volume":"10","author":"H. Steuber","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"pone.0303501.ref084","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcdb.2016.07.015","article-title":"Membrane fusion during poxvirus entry","volume":"60","author":"B. Moss","year":"2016","journal-title":"Semin. Cell. Dev. Biol."},{"issue":"11","key":"pone.0303501.ref085","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3390\/v2112409","article-title":"Development of ST-246\u00ae for treatment of poxvirus infections","volume":"2","author":"R. Jordan","year":"2010","journal-title":"Viruses"},{"issue":"1\u20132","key":"pone.0303501.ref086","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(02)00199-7","article-title":"A review of compounds exhibiting anti-orthopoxvirus activity in animal models","volume":"57","author":"D.F. Smee","year":"2003","journal-title":"Antivir. Res."},{"issue":"24","key":"pone.0303501.ref087","doi-asserted-by":"crossref","first-page":"13392","DOI":"10.1128\/JVI.00770-07","article-title":"Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly","volume":"81","author":"L. Deng","year":"2007","journal-title":"J. Virol."},{"issue":"2","key":"pone.0303501.ref088","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1017\/S0022172400024992","article-title":"Differential inhibitory effects of 5-bromodeoxyuridine on vaccinia and monkeypox viruses","volume":"81","author":"T. Yoshii","year":"1978","journal-title":"J. Hyg. (Lond)"},{"key":"pone.0303501.ref089","unstructured":"World Health Organization. (2017) WHO Advisory committee on variola virus research: report of the eighteenth meeting, 2\u20133 November 2016, Geneva, Switzerland. World Health Organization."},{"issue":"2","key":"pone.0303501.ref090","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/v12020138","article-title":"Smallpox in the post-eradication era","volume":"12","author":"H. Meyer","year":"2020","journal-title":"Viruses"},{"issue":"6","key":"pone.0303501.ref091","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1128\/AAC.01626-08","article-title":"Inhibition of vaccinia virus replication by two small interfering RNAs targeting B1R and G7L genes and their synergistic combination with cidofovir","volume":"53","author":"S. Vigne","year":"2009","journal-title":"Antimicrob. Agents. Ch."},{"issue":"3","key":"pone.0303501.ref092","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/135965350801300307","article-title":"Specific inhibition of orthopoxvirus replication by a small interfering RNA targeting the D5R gene","volume":"13","author":"S. Vigne","year":"2008","journal-title":"Antivir. Ther"},{"issue":"6","key":"pone.0303501.ref093","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1348-0421.1977.tb00296.x","article-title":"Incomplete Inhibition of Variola Virus Focus Formation in HeLa Cell Cultures by Cytosine Arabinoside","volume":"21","author":"I. Tagaya","year":"1977","journal-title":"Microbiol Immunol"},{"issue":"10","key":"pone.0303501.ref094","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1039\/C8MD00347E","article-title":"Synthesis and antiviral activity of camphor-based 1, 3-thiazolidin-4-one and thiazole derivatives as Orthopoxvirus-reproduction inhibitors","volume":"9","author":"A.S. Sokolova","year":"2018","journal-title":"Med. Chem. Comm."},{"issue":"9","key":"pone.0303501.ref095","doi-asserted-by":"crossref","first-page":"e1800157","DOI":"10.1002\/cbdv.201800153","article-title":"Discovery of a New Class of Inhibitors of Vaccinia Virus Based on (\u2212)\u2010Borneol from Abies sibirica and (+)\u2010Camphor","volume":"15","author":"A.S. Sokolova","year":"2018","journal-title":"Chem. Biodivers."},{"key":"pone.0303501.ref096","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/978-3-7643-7557-7_18","article-title":"Therapy of poxvirus infections","author":"R. Snoeck","year":"2007","journal-title":"Poxviruses"},{"issue":"11","key":"pone.0303501.ref097","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1128\/AAC.00278-11","article-title":"Identification of protein-protein interaction inhibitors targeting vaccinia virus processivity factor for development of antiviral agents","volume":"55","author":"N. Schormann","year":"2011","journal-title":"Antimicrob. Agents. Ch."},{"issue":"6","key":"pone.0303501.ref098","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1107\/S0907444907014904","article-title":"Structure-assisted discovery of Variola major H1 phosphatase inhibitors","volume":"63","author":"J. Phan","year":"2007","journal-title":"Acta. Crystallogr. D. Biol. Crystallogr"},{"issue":"9","key":"pone.0303501.ref099","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1021\/jm101554k","article-title":"Identification of inhibitors that block vaccinia virus infection by targeting the DNA synthesis processivity factor D4","volume":"54","author":"M. Nuth","year":"2011","journal-title":"J. Med. Chem."},{"issue":"20","key":"pone.0303501.ref100","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge","volume":"79","author":"G. Yang","year":"2005","journal-title":"J. Virol."},{"issue":"11","key":"pone.0303501.ref101","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/jmv.25544","article-title":"Screening and evaluation of potential inhibitors against vaccinia virus from 767 approved drugs","volume":"91","author":"J.J. Wu","year":"2019","journal-title":"J. Med. Virol."},{"key":"pone.0303501.ref102","article-title":"A PBPK Model of Ternary Cyclodextrin Complex of ST-246 Was Built to Achieve a Reasonable IV Infusion Regimen for the Treatment of Human Severe Smallpox","volume":"13","author":"Z. Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"11","key":"pone.0303501.ref103","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.3390\/molecules27113577","article-title":"Development and Validation of a Method of Liquid Chromatography Coupled with Tandem Mass Spectrometry for Quantification of ST-246 (Tecovirimat) in Human Plasma","volume":"27","author":"G.A. Oleinik","year":"2022","journal-title":"Molecules"},{"key":"pone.0303501.ref104","first-page":"219","article-title":"Structure-based drug designing. Bioinformatics","author":"S. Pant","year":"2022","journal-title":"Academic. Press."},{"issue":"8","key":"pone.0303501.ref105","doi-asserted-by":"crossref","first-page":"e3000790","DOI":"10.1371\/journal.pbio.3000790","article-title":"Cryo-EM structure of the human concentrative nucleoside transporter CNT3","volume":"18","author":"Y. Zhou","year":"2020","journal-title":"PLoS Boil"},{"issue":"9","key":"pone.0303501.ref106","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41594-021-00650-1","article-title":"AlphaFold2 and the future of structural biology","volume":"28","author":"P. Cramer","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"9","key":"pone.0303501.ref107","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/prot.26138","article-title":"AlphaFold2 predicts the inward\u2010facing conformation of the multidrug transporter LmrP","volume":"89","author":"D.D. Alamo","year":"2021","journal-title":"Proteins"},{"issue":"1","key":"pone.0303501.ref108","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5958\/0974-4150.2021.00014.6","article-title":"Review on discovery studio: An important tool for molecular docking","volume":"14","author":"S.S. Pawar","year":"2021","journal-title":"Asian. J. Res. Chem."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0303501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T18:26:22Z","timestamp":1733509582000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0303501"}},"subtitle":[],"editor":[{"given":"Sheikh Arslan","family":"Sehgal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":108,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0303501","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]}}}